Related Experiment Video
Updated: May 27, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania
Daudi O Simba1, Deodatus Kakoko, Goran Tomson
1Department of Community Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. dsimba@muhas.ac.tz
Insights
High adherence to artemether/lumefantrine (ALu) malaria treatment was reported in rural Tanzania. Factors like household wealth influenced adherence, crucial for preventing drug resistance.
Area of Science:
- Malariology
- Pharmacology
- Global Health
Background:
- Artemether/lumefantrine (ALu) is a key malaria treatment.
- Understanding adherence is vital for treatment efficacy and resistance prevention.
Purpose of the Study:
- To assess adherence to ALu treatment in rural Tanzania.
- To identify factors associated with ALu adherence.
- To measure lumefantrine concentrations in children.
Main Methods:
- Follow-up study in five Tanzanian villages.
- Home visits on Day 7 post-treatment for adherence interviews.
- Malaria rapid diagnostic tests and capillary blood collection for lumefantrine levels.
Main Results:
- 88.3% of children reportedly received all ALu doses on time.
- Non-adherence was primarily due to untimeliness, especially for later doses.
- No significant difference in blood lumefantrine concentrations between adherent and non-adherent groups.
- Children from less poor households showed higher adherence (aOR=2.23).
Conclusions:
- Reported ALu adherence in rural Tanzania is high and encouraging.
- Socioeconomic status is a factor influencing adherence.
- Variability in lumefantrine levels may stem from dosage and healthcare worker practices.
Abstract:
A follow-up study was conducted to determine the magnitude of and factors related to adherence to artemether/lumefantrine (ALu) treatment in rural settings in Tanzania. Children in five villages of Kilosa District treated at health facilities were followed-up at their homes on Day 7 after the first dose of ALu. For those found to be positive using a rapid diagnostic test for malaria and treated with ALu, their caretakers were interviewed on drug administration habits. In addition, capillary blood samples were collected on Day 7 to determine lumefantrine concentrations. The majority of children (392/444; 88.3%) were reported to have received all doses, in time. Non-adherence was due to untimeliness rather than missing doses and was highest for the last two doses. No significant difference was found between blood lumefantrine concentrations among adherent (median 286 nmol/l) and non-adherent [median 261 nmol/l; range 25 nmol/l (limit of quantification) to 9318 nmol/l]. Children from less poor households were more likely to adhere to therapy than the poor [odds ratio (OR)=2.45, 95% CI 1.35-4.45; adjusted OR=2.23, 95% CI 1.20-4.13]. The high reported rate of adherence to ALu in rural areas is encouraging and needs to be preserved to reduce the risk of emergence of resistant strains. The age-based dosage schedule and lack of adherence to ALu treatment guidelines by health facility staff may explain both the huge variability in observed lumefantrine concentrations and the lack of difference in concentrations between the two groups.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors

